Premark Pharma’s primary business objective is to achieve a marketing approval in EU and US for the first prescription treatment for blepharitis. Blepharitis is a common, chronic inflammatory eye disease for which there is currently no approved treatment
This company has no org chart yet
This company has no teams yet
This company has no offices yet